TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism

Background Transforming growth factor-β (TGFβ) is emerging as a promising target for cancer therapy, given its ability to promote progression of advanced tumors and to suppress anti-tumor immune responses. However, TGFβ also plays multiple roles in normal tissues, particularly during organogenesis,...

詳細記述

書誌詳細
主要な著者: Canè, S, Van Snick, J, Uyttenhove, C, Pilotte, L, Van den Eynde, BJ
フォーマット: Journal article
言語:English
出版事項: BMJ Publishing Group 2021

類似資料